University of California San Francisco
Give to UCSFWith 10 days to go before AIDS Walk San Francisco, UCSF is working to get members of the University community to sign up for or contribute to the annual fundraiser to support programs and services to treat and prevent HIV/AIDS.
A new study by UCSF researchers points to changes in intestinal bacteria as a possible explanation for why successfully treated HIV patients nonetheless experience life-shortening chronic diseases.
Two veteran UCSF doctors who have been battling the AIDS epidemic for decades retraced past efforts and described their ongoing quest for a cure for HIV in the Academic Senate’s Third Annual Faculty Research Lecture.
UC San Francisco, a frequent high-performing team at AIDS Walk San Francisco, will again for the gold – the honor given to the top fundraising organizations participating in the annual event.
<p>Community intervention with free mobile HIV testing and counseling, same-day results and post-test support led to a 14 percent reduction in new HIV infections in targeted communities in Sub-Saharan Africa, according to results of a large randomized, controlled trial.</p>
<p>UCSF and the Gladstone Institutes will observe World AIDS Day on December 3 with a symposium featuring emerging investigators working to combat the disease.</p>
<p>Global health pioneer Paul Farmer, MD, PhD, addressed a packed UCSF auditorium in a special lecture about a community-based health care model that his nonprofit organization, Partners In Health, has brought to some of the world's most impoverished countries, including Haiti and Rwanda.</p>
<p>The National Institutes of Health has awarded more than $15 million over the next five years to the UCSF-Gladstone Center for AIDS Research (CFAR) to continue its pioneering translational AIDS research.</p>
Starting HIV-infected patients on antiretroviral therapy reduces food insecurity and improves physical health, thereby contributing to the disruption of a lethal syndemic, UCSF and Massachusetts General Hospital researchers have found in a study focused on sub-Saharan Africa.
Scientists at the UCSF-affiliated Gladstone Institutes have devised a method to track HIV inside individual cells — an important development for understanding “HIV latency" when the virus goes dormant after the patient begins antiretroviral treatment.
New research from an international team of HIV/AIDS experts has reaffirmed the effectiveness of Truvada — the first and only medication approved by the FDA for HIV prevention.